LDL cholesterol

Biomarker24 papers9 findings

  • Human trial3
  • Humans12

Interventions

6

Diet

downin humans1

1 study
  1. Diet decreases LDL cholesterol in humans.

    “LDL-cholesterol decreased in both Opti and LCHF Opti groups versus control”

    Human trial4 weeks

    Optimized Nutri-Dense meals versus a low-carbohydrate high-fat diet: an exploratory randomized controlled trial · Scientific reports · 3 Oct 2026

Diet →

Tirzepatide

downin humans1

1 study
  1. Tirzepatide decreases LDL cholesterol in humans.

    Humanstype 2 diabetes4.5 ± 1.0 mg/week24 weeksn = 88

    Real-world effectiveness and safety of low-dose tirzepatide in Japanese people with type 2 diabetes: a multicenter, retrospective, single-arm, observational study-East Shizuoka Tirzepatide (ESTATE) study · Endocrine journal · 29 Sep 2026

Tirzepatide →

Statins

downin humans1

1 study
  1. Statins decrease LDL cholesterol in humans (donut estimates vary from - 1.00 to - 1.72 mmol/L).

    Humansaround the first recorded prescription date

    Event-time regression discontinuity for biomedical data: LATT estimation and covariate distribution tests · American journal of epidemiology · 29 Sep 2026

Statins →

Inclisiran

downin humans1

1 study
  1. Inclisiran decreases LDL cholesterol in humans (-46% (-60.8 to -33.8%)).

    Humans3 years43.1% femalesn = 109

    Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network · Clinical research in cardiology : official journal of the German Cardiac Society · 28 Sep 2026

Inclisiran →

Lerodalcibep

downin humans1

1 study
  1. Lerodalcibep decreases LDL cholesterol in humans (50% to 65%).

    Reviewin patients with heterozygous familial hypercholesterolemia, established cardiovascular disease, or high cardiovascular riskmonthly

    Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia · The Annals of pharmacotherapy · 25 Sep 2026

Lerodalcibep →

Mediterranean diet

downin humans1

1 study
  1. Mediterranean diet decreases LDL cholesterol in humans.

    Review

    Lifestyle Medicine and the Science of Cholesterol Reduction: A Systematic Review of Non-medication Approaches Among Adults · Cureus · 30 Aug 2026

Mediterranean diet →

Upstream

2

Cysteine-glutathione disulfide

upin humans1

1 study
  1. Cysteine-glutathione disulfide increases LDL cholesterol in humans.

    “Genetically predicted 2-amino-octanoate and cysteine-glutathione disulfide demonstrated strong and reproducible positive interaction effects with LDL levels in statin users”

    Humansin statin users

    Gene-Environment Interaction Mendelian Randomization Reveals Statin-Dependent Associations Between Metabolites and Lipid Traits · Pharmaceuticals (Basel, Switzerland) · 17 Sep 2026

Cysteine-glutathione disulfide →

2-amino-octanoate

upin humans1

1 study
  1. 2-amino-octanoate increases LDL cholesterol in humans.

    “Genetically predicted 2-amino-octanoate and cysteine-glutathione disulfide demonstrated strong and reproducible positive interaction effects with LDL levels in statin users”

    Humansin statin users

    Gene-Environment Interaction Mendelian Randomization Reveals Statin-Dependent Associations Between Metabolites and Lipid Traits · Pharmaceuticals (Basel, Switzerland) · 17 Sep 2026

2-amino-octanoate →

Associations

1

APOE

upin humans1

1 study
  1. APOE is associated with LDL cholesterol in humans.

    Reviewε4 isoform

    Apolipoprotein E ε3/ε4 and coronary artery disease: lipid and non-lipid mechanisms in personalized prevention - narrative review · Frontiers in cardiovascular medicine · 18 Sep 2026

APOE →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 21Oct 2026: 529
medRxivHumansPreprint

Retinal vascular changes track mortality risk in humans

Increased retinal fractal dimension carried a mortality hazard ratio of 0.92 per standard deviation, whereas arteriolar widening carried a hazard…Increased retinal fractal dimension carried a mortality hazard ratio of 0.92 per standard deviation, whereas arteriolar widening carried a hazard ratio of 1.09.

medRxivHumansPreprint

Social context predicts heart risks despite normal biomarkers

Below target cutoffs, participants with less favorable social context had cardiovascular event rates of 3.39 versus 1.68, 7.16 versus 2.05, and 8.67…Below target cutoffs, participants with less favorable social context had cardiovascular event rates of 3.39 versus 1.68, 7.16 versus 2.05, and 8.67 versus 2.34 per 1,000 person-years.